Biotech

All Articles

Arch shuts $3B-plus fund to promote biopharma startups

.On the heels of a $3 billion fund from Bain Resources Life Sciences, Arc Project Partners is actual...

Orion to make use of Aitia's 'electronic identical twins' to find new cancer medicines

.Finnish biotech Orion has spied prospective in Aitia's "electronic identical twin" tech to cultivat...

Windtree's shock med rears blood pressure in most up-to-date stage 2 succeed

.While Windtree Therapeutics has actually strained to develop the economic origins needed to make it...

2 cancer biotechs merge, developing international footprint

.OncoC4 is actually taking AcroImmune-- and its own internal clinical production capabilities-- unde...

Amgen files first period 3 win for $400M chronic eczema drug

.Amgen has actually discussed (PDF) the initial phase 3 information on its $400 million chronic ecze...

Biogen, UCB record period 3 lupus succeed after neglecting earlier test

.Biogen as well as UCB's bank on advancing into period 3 on the back of an unsuccessful study aims t...

Aptadir really hopes brand-new RNA inhibitors can reverse challenging cancers cells

.Italian biotech Aptadir Therapies has actually released along with the guarantee that its pipe of p...

Wave surfs DMD success to regulatory authorities' doors, sending stockpile

.Wave Life Sciences has actually met its own target in a Duchenne muscular dystrophy (DMD) research,...

Sanofi picks brand-new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma cre...

Achilles trickles cell treatment course, supports for layoffs after skipping 'office viability' targets

.Achilles Rehabs has actually torn up its approach. The British biotech is knocking off on its clini...